S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.

Neoplastic growth is associated with increased polyamine biosynthetic activity and content. Tumor promoter treatment induces the rate-limiting enzymes in polyamine biosynthesis, ornithine decarboxylase (ODC), and S-adenosylmethionine decarboxylase (AdoMetDC), and targeted ODC overexpression is sufficient for tumor promotion in initiated mouse skin. We generated a mouse model with doxycycline (Dox)-regulated AdoMetDC expression to determine the impact of this second rate-limiting enzyme on epithelial carcinogenesis. TetO-AdoMetDC (TAMD) transgenic founders were crossed with transgenic mice (K5-tTA) that express the tetracycline-regulated transcriptional activator within basal keratinocytes of the skin. Transgene expression in TAMD/K5-tTA mice was restricted to keratin 5 (K5) target tissues and silenced upon Dox treatment. AdoMetDC activity and its product, decarboxylated AdoMet, both increased approximately 8-fold in the skin. This enabled a redistribution of the polyamines that led to reduced putrescine, increased spermine, and an elevated spermine:spermidine ratio. Given the positive association between polyamine biosynthetic capacity and neoplastic growth, it was somewhat surprising to find that TAMD/K5-tTA mice developed significantly fewer tumors than controls in response to 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate chemical carcinogenesis. Importantly, tumor counts in TAMD/K5-tTA mice rebounded to nearly equal the levels in the control group upon Dox-mediated transgene silencing at a late stage of tumor promotion, which indicates that latent viable initiated cells remain in AdoMetDC-expressing skin. These results underscore the complexity of polyamine modulation of tumor development and emphasize the critical role of putrescine in tumor promotion. AdoMetDC-expressing mice will enable more refined spatial and temporal manipulation of polyamine biosynthesis during tumorigenesis and in other models of human disease.

[1]  P. Welsh,et al.  Spermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis , 2012, Cancer biology & therapy.

[2]  A. Paasinen-Sohns,et al.  Chaotic neovascularization induced by aggressive fibrosarcoma cells overexpressing S-adenosylmethionine decarboxylase. , 2011, The international journal of biochemistry & cell biology.

[3]  L. Alhonen,et al.  Polyamines and hair: a couple in search of perfection , 2010, Experimental dermatology.

[4]  M. Pomplun,et al.  A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer , 2010, Cancer Prevention Research.

[5]  C. Kahana.  Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. , 2009, Essays in biochemistry.

[6]  A. Pegg.  S-Adenosylmethionine decarboxylase. , 2009, Essays in biochemistry.

[7]  A. Pegg.  Mammalian polyamine metabolism and function , 2009, IUBMB life.

[8]  K. Kiguchi,et al.  Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications , 2009, Nature Protocols.

[9]  C. Vinson,et al.  Inhibition of CREB Function in Mouse Epidermis Reduces Papilloma Formation , 2009, Molecular Cancer Research.

[10]  Mark A. Hall,et al.  Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma. , 2009, Cancer research.

[11]  Edward S. Kim,et al.  Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial , 2008, Cancer Prevention Research.

[12]  A. Pegg,et al.  Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. , 2008, American journal of physiology. Endocrinology and metabolism.

[13]  S. Merali,et al.  Polyamine Acetylation Modulates Polyamine Metabolic Flux, a Prelude to Broader Metabolic Consequences* , 2008, Journal of Biological Chemistry.

[14]  A. Mahan.  Retrospect and Prospect , 2007 .

[15]  S. Gilmour.  Polyamines and nonmelanoma skin cancer. , 2007, Toxicology and applied pharmacology.

[16]  P. Woster,et al.  Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis. , 2007, Carcinogenesis.

[17]  L. Shantz,et al.  Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion‐sensitive and promotion‐resistant genetic backgrounds , 2007, Molecular carcinogenesis.

[18]  L. Marton,et al.  Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases , 2007, Nature reviews. Drug discovery.

[19]  V. Levin,et al.  Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential , 2007, Amino Acids.

[20]  A. Pegg,et al.  Polyamines and neoplastic growth. , 2007, Biochemical Society transactions.

[21]  A. Pegg.  Regulation of Ornithine Decarboxylase* , 2006, Journal of Biological Chemistry.

[22]  L. Shantz,et al.  Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis. , 2006, Carcinogenesis.

[23]  L. Alhonen,et al.  Genetic manipulation of polyamine catabolism in rodents. , 2006, Journal of biochemistry.

[24]  L. Alhonen,et al.  Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. , 2005, Cancer research.

[25]  J. Cleveland,et al.  Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. , 2005, Cancer cell.

[26]  J. Cleveland,et al.  Haploinsufficiency for odc modifies mouse skin tumor susceptibility. , 2005, Cancer research.

[27]  B. Foster,et al.  Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice* , 2004, Journal of Biological Chemistry.

[28]  Hong Zhang,et al.  Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. , 2004, The Journal of clinical investigation.

[29]  L. Alhonen,et al.  Genetic approaches to the cellular functions of polyamines in mammals. , 2004, European journal of biochemistry.

[30]  A. Hughes,et al.  A perspective of polyamine metabolism. , 2003, The Biochemical journal.

[31]  N. Seiler,et al.  Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. , 2003, Current drug targets.

[32]  C. Conti,et al.  Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice. , 2003, Carcinogenesis.

[33]  Robert D Cardiff,et al.  Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. , 2003, Genes & development.

[34]  A. Pegg,et al.  Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis. , 2002, Carcinogenesis.

[35]  K. Kashiwagi,et al.  Essential role of S‐adenosylmethionine decarboxylase in mouse embryonic development , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[36]  J. Martial,et al.  The Ornithine Decarboxylase Gene Is Essential for Cell Survival during Early Murine Development , 2001, Molecular and Cellular Biology.

[37]  R Paus,et al.  A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. , 2001, The Journal of investigative dermatology.

[38]  O. Jänne,et al.  C-Jun Activation-Dependent Tumorigenic Transformation Induced Paradoxically by Overexpression or Block of S-Adenosylmethionine Decarboxylase , 2000, The Journal of cell biology.

[39]  A. Glick,et al.  Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. , 2000, The Journal of investigative dermatology.

[40]  M K Smith,et al.  Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. , 1998, Carcinogenesis.

[41]  T G O'Brien,et al.  Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. , 1997, Cancer research.

[42]  T. Bestor,et al.  Interference with DNA Methyltransferase Activity and Genome Methylation during F9 Teratocarcinoma Stem Cell Differentiation Induced by Polyamine Depletion* , 1997, The Journal of Biological Chemistry.

[43]  M. H. Hardy,et al.  The secret life of the hair follicle. , 1992, Trends in genetics : TIG.

[44]  T G O'Brien,et al.  Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. , 1991, Carcinogenesis.

[45]  J. Jänne,et al.  Inhibition of DNA and protein synthesis in UV-irradiated mouse skin by 2-difluoromethylornithine, methylglyoxal bis(guanylhydrazone), and their combination. , 1983, The Journal of investigative dermatology.

[46]  M. Takigawa,et al.  Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. , 1982, Biochemical and biophysical research communications.

[47]  T G O'Brien,et al.  The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. , 1976, Cancer research.

[48]  D. Feith.  Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolism. , 2011, Methods in molecular biology.

[49]  C. Schwartz,et al.  Spermine synthase activity affects the content of decarboxylated S-adenosylmethionine. , 2011, The Biochemical journal.

[50]  K. Kashiwagi,et al.  Modulation of cellular function by polyamines. , 2010, The international journal of biochemistry & cell biology.

[51]  E. Gerner,et al.  Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy. , 2006, Journal of biochemistry.

[52]  L. Shantz,et al.  Overproduction of cardiac S-adenosylmethionine decarboxylase in transgenic mice. , 2006, The Biochemical journal.

[53]  L. Shantz,et al.  Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway. , 1999, The international journal of biochemistry & cell biology.

[54]  Gary A. Boorman,et al.  Pathology of the Mouse: Reference and Atlas , 1999 .

[55]  G. Scalabrino,et al.  Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy. , 1985, Cancer detection and prevention.